Advertisements


We are Sorry, This Page doesn't Exist


Vertex Hits Stumbling Block For One Triple-Combo Therapy For Cystic Fibrosis

Vertex Hits Stumbling Block For One Triple-Combo Therapy For Cystic Fibrosis.....»»

Category: topSource: seekingalphaApr 30th, 2018

BioMarin shares rise on FDA approval of rare metabolic disorder drug

BioMarin Pharmaceutical Inc. shares rose in the extended session Thursday after the Food and Drug Administration approved the biotech's treatment for a rare metabolic disorder. Biomarin shares rose 4.8% after hours, foll.....»»

Category: topSource: marketwatch11 hr. 45 min. ago

Botox Rival Evolus Roars Back With 123% Rally Despite FDA Delay

Evolus Inc. is reaching new highs, shrugging off a delay of potential approval of its Botox-rivaling wrinkle treatment......»»

Category: topSource: moneycentral14 hr. 30 min. ago

Amgen Wins Another FDA Approval

Amgen shares made a slight gain on Tuesday after it was announced that the FDA approved its treatment of glucocorticoid-induced osteoporosis in men and women at high risk of fracture......»»

Category: blogSource: 247wallstMay 22nd, 2018

AstraZeneca"s Lokelma Gains FDA Nod to Treat Hyperkalemia

AstraZeneca's (AZN) Lokelma secures an FDA approval for the treatment of hyperkalemia in adults. .....»»

Category: dealsSource: nytMay 21st, 2018

Migraine Space in Focus as AMGN/NVS" Aimovig Gets FDA Nod

Migraine is one of the top 10 causes of years lived with disability globally. With Aimovig receiving FDA approval for treatment of migraine, investors' attention is on future regulatory decisions. .....»»

Category: smallbizSource: nytMay 21st, 2018

Amgen’s Novel Migraine Treatment Gets Key Approval

Amgen shares saw a nice bump after the FDA on Thursday approved its preventive treatment of migraine in adults......»»

Category: blogSource: 247wallstMay 18th, 2018

Ecochlor just beginning to keep its head above the water

Ecochlor Inc., which has 27 employees, has spent more than a decade developing and getting regulatory approval for its ballast water treatment business......»»

Category: topSource: bizjournalsMay 17th, 2018

Amgen receives FDA approval for Aimovig in migraine treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2018

Startup aims to give castoff Vertex drug new life as Alzheimer’s treatment

In 2001, Vertex Pharmaceuticals announced that it was halting development of a rheumatoid arthritis drug. The treatment, which was designed to block a certain enzyme linked to inflammation, had showed promise in clinical trials, but animal studies .....»»

Category: topSource: bizjournalsMay 16th, 2018

This daily facial treatment is pricey, but it"s the only thing that"s helped to prevent and clear up my cystic acne and uneven skin

The Insider Picks team writes about stuf.....»»

Category: topSource: businessinsiderMay 15th, 2018

BioCryst receives EMA approval for ALPIVAB for treatment of influenza

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 1st, 2018

Kidney disease treatment with roots in KC wins approval after 36 years

The Food and Drug Administration gave the green light for the first approved treatment for polycystic kidney disease on Tuesday — a treatment based on research that traces its roots to Kansas City. In the 1960s, late University of Kansas Medical .....»»

Category: topSource: bizjournalsApr 25th, 2018

Glenmark Pharma gets USFDA nod for scalp and skin treatment drug

The company's current portfolio consists of 133 products authorised for distribution at the US marketplace and 60 abbreviated new drug applications pending approval with the USFDA.....»»

Category: topSource: business-standardApr 20th, 2018

FDA Panel Backs Proposed Epilepsy Drug Derived From Cannabis

An FDA advisory panel recommended approval of what could become the first prescription drug in the U.S. derived from the marijuana plant, as a treatment for people with rare forms of epilepsy......»»

Category: smallbizSource: wsjApr 19th, 2018

Krystal Biotech receives approval in Europe for gene therapy treatment

A gene therapy company has received a designation for one of its treatments from the European Medicines Agency. Krystal Biotech, developing and commercializing novel treatments for dermatological diseases, announced that KB103, a treatment for a sever.....»»

Category: topSource: bizjournalsApr 19th, 2018

Rigel Pharmaceuticals Gets No Boost From FDA Approval

Rigel Pharmaceuticals shares retreated early Wednesday despite an approval from the FDA for its treatment of thrombocytopenia......»»

Category: blogSource: 247wallstApr 18th, 2018

GW Pharma seen nearing historic approval for cannabinoid epilepsy treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 18th, 2018

Intercept Reports Phase III Sub-Study Liver Biopsy Data

Intercept (ICPT) announces data from the POISE biopsy sub-study which showed that treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patien.....»»

Category: worldSource: nytApr 16th, 2018

Alkermes Wins Big on FDA Approval

Shares of Alkermes saw a handy gain to start out the week after the FDA made a critical decision about its treatment for major depressive disorder......»»

Category: blogSource: 247wallstApr 16th, 2018